Bluepha is a cutting-edge synthetic biotech company that specializes in molecular and material innovation. Our core team consists of experts from top universities and research institutes, including Tsinghua University, Peking University, and the Chinese Academy of Sciences, as well as experienced professionals from Fortune 500 companies. Our advisory panel comprises renowned pioneers in the field of synthetic biotechnology production, study, and research. Since our establishment in October 2016, we have been committed to designing, developing, manufacturing, and sales of bio-based polymer products, including marine biodegradable PHA resins, regenerative medicine products, functional ingredients for personal care and medical beauty, and probiotic products. We collaborate with business partners from various industries, including consumer goods, food, health and medical care, agriculture, and industrial engineering. Our aim is to help them differentiate their products and gain a competitive advantage. In 2022, we completed the construction of our first industrial-scale facility, BioFAB1, in Yancheng, which has the capacity to produce 5,000 tonnes of Bluepha PHA resins annually, laying a robust foundation for the stable supply of PHA. As of February 2023, we have raised about 300 million dollars from several well-known domestic investors. Our R&D centers and offices are strategically located across Beijing, Shenzhen, Shanghai, and Jiangsu Province. We are proud to work with many Fortune 500 companies in the food and consumer goods industry.